Mirum’s Experimental Hepatitis Drug Meets Late-Stage Trial Goal
ISLAMABAD: (News Desk) - Mirum Pharmaceuticals said on Monday that its experimental hepatitis treatment, brelovitug, met the primary goal of a late-stage clinical trial by reducing hepatitis D virus levels in patients with the rare liver…